Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiota ecosystem is a complex consortium of microorganisms that provides a protective barrier against pathogens through a phenomenon known as colonization resistance (Britton & Young, 2014, Gastroenterology). Clostridioides difficile exploits an ecological niche that becomes available when this community is disrupted, typically by antibiotic treatment that reduces microbial diversity and alters the metabolic environment (Seekatz & Young, 2014, J. Clin. Invest.). In a healthy ecosystem, commensal bacteria compete with C. difficile for limited nutrients and produce metabolites, such as secondary bile acids, that directly inhibit its vegetative growth (Buffie et al., 2015, Nature). Therapeutic interventions like fecal microbiota transplantation (FMT) or live biotherapeutic products (e.g., Vowst, Rebyota) aim to re-populate this niche with diverse commensals to restore these inhibitory mechanisms (FDA, 2023, Vowst Prescribing Information). This ecological approach shifts the treatment paradigm from direct pathogen eradication to the restoration of a resilient microbial community capable of self-regulating against infection.
Restoration of colonization resistance through competitive exclusion for nutrients and the enzymatic conversion of primary bile acids to secondary bile acids, which inhibits C. difficile vegetative growth (Buffie et al., 2015, Nature; Britton & Young, 2014, Gastroenterology).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota ecosystem and Clostridioides difficile ecological niche.